Literature DB >> 2846405

Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma.

H Tsuda1, S Hirohashi, Y Shimosato, M Terada, H Hasegawa.   

Abstract

We present details of two separate nodular lesions of atypical adenomatous hyperplasia, within one of which a small area of overt hepatocellular carcinoma was detected. The patient was positive for serum hepatitis B surface antigen, and Southern blot analysis revealed that deoxyribonucleic acid from the lesions of hepatocellular carcinoma and surrounding atypical adenomatous hyperplasia showed the same restriction pattern of integrated hepatitis B virus deoxyribonucleic acid, indicating that the two lesions were derived from an identical clone. It was also indicated that the two separate lesions of atypical adenomatous hyperplasia were independently derived through clonal expansion of different cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846405     DOI: 10.1016/s0016-5085(88)80093-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  28 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

Review 2.  Ethanol injection for the treatment of hepatic tumours.

Authors:  C Bartolozzi; R Lencioni
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

3.  Cytophotometric DNA analysis of adenomatous hyperplasia in cirrhotic livers.

Authors:  M Hoso; Y Nakanuma
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Early HCC: diagnosis and molecular markers.

Authors:  Michiie Sakamoto
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

5.  Amplification of BCR protein associated with oncogenesis in human hepatocellular carcinoma.

Authors:  Y Miyazaki; T Mitsuma; T Ichida; H Odazima; K Ishihara; H Asakura
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

6.  Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.

Authors:  Hidenori Toyoda; Takashi Kumada; Toshifumi Tada; Yasuhiro Sone; Atsuyuki Maeda; Yuji Kaneoka
Journal:  Hepatol Int       Date:  2014-07-23       Impact factor: 6.047

7.  Id2 leaves the chromatin of the E2F4-p130-controlled c-myc promoter during hepatocyte priming for liver regeneration.

Authors:  José L Rodríguez; Juan Sandoval; Gaetano Serviddio; Juan Sastre; María Morante; Maria-Giulia Perrelli; María L Martínez-Chantar; José Viña; Juan R Viña; José M Mato; Matías A Avila; Luis Franco; Gerardo López-Rodas; Luis Torres
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

8.  Histopathological and morphometric analysis of atypical adenomatous hyperplasia of human cirrhotic livers.

Authors:  T Terada; K Ueda; Y Nakanuma
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  A case report of hepatocellular carcinoma within adenomatous hyperplasia: is adenomatous hyperplasia a precancerous lesion or not?

Authors:  A Itoh; H Taniguchi; K Sawai; T Takahashi; K Kawamoto; T Deguchi; K Kagawa
Journal:  Gastroenterol Jpn       Date:  1991-08

10.  Overexpression of DNA methyltransferase 1 and its biological significance in primary hepatocellular carcinoma.

Authors:  Hong Fan; Zhu-Jiang Zhao; Jian Cheng; Xian-Wei Su; Qing-Xiang Wu; Yun-Feng Shan
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.